These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 11201362)

  • 21. Risk factors for adult T-cell leukemia among carriers of human T-lymphotropic virus type I.
    Hisada M; Okayama A; Shioiri S; Spiegelman DL; Stuver SO; Mueller NE
    Blood; 1998 Nov; 92(10):3557-61. PubMed ID: 9808547
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibodies to human T-cell lymphotropic virus type I (HTLV-I) by particle agglutination (PA) test in Korean blood donors.
    Kim JM; Song YG; Oho YC; Park HC; Kwon KH; Kim E; Lee SH; Kim KH
    Yonsei Med J; 1999 Apr; 40(2):173-7. PubMed ID: 10333722
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serological, epidemiological, and molecular differences between human T-cell lymphotropic virus Type 1 (HTLV-1)-seropositive healthy carriers and persons with HTLV-I Gag indeterminate Western blot patterns from the Caribbean.
    Rouet F; Meertens L; Courouble G; Herrmann-Storck C; Pabingui R; Chancerel B; Abid A; Strobel M; Mauclere P; Gessain A
    J Clin Microbiol; 2001 Apr; 39(4):1247-53. PubMed ID: 11283036
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Determination of anti-HTLV-I/II antibodies: Experience in 28,897 blood donations in Buenos Aires].
    Blejer JL; Saguier MC; Salamone HJ; Carreras LA
    Sangre (Barc); 1995 Dec; 40(6):447-51. PubMed ID: 8850226
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reevaluation of confirmatory tests for human T-cell leukemia virus Type 1 using a luciferase immunoprecipitation system in blood donors.
    Furuta RA; Ma G; Matsuoka M; Otani S; Matsukura H; Hirayama F
    Transfusion; 2015 Apr; 55(4):880-9. PubMed ID: 25363675
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of HTLV-I virus in blood donors and transfusion in Mali: Implications for blood safety.
    Diarra AB; Kouriba B; Guindo A; Maiga AI; Diabaté DT; Douyon I; Diawara SI; Touré BA; Fonkoro S; Murphy EL; Diallo DA
    Transfus Clin Biol; 2014 Jun; 21(3):139-42. PubMed ID: 24948205
    [No Abstract]   [Full Text] [Related]  

  • 27. Seroprevalence of HTLV-I/II in blood donors in Monterrey, Mexico.
    Trejo-Avila LM; Fuentes-Pensamiento R; Scorro Flores-Castañeda M; Diaz-Mendoza ML; Zapata-Benavides P; Tamez-Guerra RS
    Arch Med Res; 1996; 27(1):97-9. PubMed ID: 8867376
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Seroprevalence and geographical distribution of human T-lymphotropic virus type 1 among volunteer blood donors in endemic areas of Iran.
    Karimi G; Zadsar M; Pourfathollah AA
    Virol J; 2017 Jan; 14(1):14. PubMed ID: 28137274
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Seroprevalence and molecular epidemiology of human T-Cell leukemia virus type 1 (HTLV-1) and HTLV-2 in blood donors from Dakar, Senegal.
    Diop S; Calattini S; Abah-Dakou J; Thiam D; Diakhaté L; Gessain A
    J Clin Microbiol; 2006 Apr; 44(4):1550-4. PubMed ID: 16597891
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of antibodies to human T cell leukaemia/lymphoma virus in blood donors in north London.
    Brennan M; Runganga J; Barbara JA; Contreras M; Tedder RS; Garson JA; Tuke PW; Mortimer PP; McAlpine L; Tosswill JH
    BMJ; 1993 Nov; 307(6914):1235-9. PubMed ID: 8281054
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A seroepidemiological survey of HTLV-I/II carriers in the Puna Jujeña.
    Dipierri JE; Tajima K; Cartier Robirosa L; Sonoda S
    Medicina (B Aires); 1999; 59(6):717-20. PubMed ID: 10752214
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pathogenesis and prevention of HTLV-1-associated diseases.
    Miwa M; Kushida S; Maeda N; Fang J; Kawamura T; Kameyama T; Uchida K
    Leukemia; 1997 Apr; 11 Suppl 3():65-6. PubMed ID: 9209300
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Seroprevalence of HTLV-I in Cheju Island, a Korean island adjacent to the endemic area of Japan.
    Kim JM; Chang KH; Choi YH; Song YG; Kang SM; Yoon TY; Choi JM; Park SY; Lew DJ
    J Acquir Immune Defic Syndr; 1999 Dec; 22(4):409-12. PubMed ID: 10634207
    [No Abstract]   [Full Text] [Related]  

  • 34. Laboratory characterization of human T cell lymphotropic virus types 1 (HTLV-1) and 2 (HTLV-2) infections in blood donors from Sao Paulo, Brazil.
    Segurado AA; Malaque CM; Sumita LM; Pannuti CS; Lal RB
    Am J Trop Med Hyg; 1997 Aug; 57(2):142-8. PubMed ID: 9288805
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The seroprevalence of HTLV-I in patients with ocular diseases, pregnant women and healthy volunteers in the Kanto district, central Japan.
    Goto K; Sato K; Kurita M; Masuhara N; Iijima Y; Saeki K; Ohno S
    Scand J Infect Dis; 1997; 29(3):219-21. PubMed ID: 9255878
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of antibody to human T-cell lymphotropic virus type I in Okinawa, Japan, after an interval of 9 years.
    Morofuji-Hirata M; Kajiyama W; Nakashima K; Noguchi A; Hayashi J; Kashiwagi S
    Am J Epidemiol; 1993 Jan; 137(1):43-8. PubMed ID: 8434571
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Seroepidemiological survey of HTLV-I infection in French Polynesia, Cook Islands and Fiji.
    Chungue E; Boutin JP; Le Marchand L; Philippon G; Le Guellec A; Chanteau S; Cartel JL; Gras C; Martin PM; Roux JF
    Eur J Epidemiol; 1993 May; 9(3):347-50. PubMed ID: 8405324
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Seroprevalence of six different viruses among pregnant women and blood donors in rural and urban Burkina Faso: A comparative analysis.
    Collenberg E; Ouedraogo T; Ganamé J; Fickenscher H; Kynast-Wolf G; Becher H; Kouyaté B; Kräusslich HG; Sangaré L; Tebit DM
    J Med Virol; 2006 May; 78(5):683-92. PubMed ID: 16555290
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High prevalence of HTLV-I infection among the family members of a patient with adult T-cell leukemia/lymphoma from northeastern Japan.
    Shimizu K
    Am J Hematol; 1999 May; 61(1):78-81. PubMed ID: 10331515
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Seroepidemiology of HTLV-I infection in northeast Thailand: a four year surveillance.
    Urwijitaroon Y; Barusrux S; Puapairoj C; Romphruk A; Khampeera P
    J Med Assoc Thai; 1997 Sep; 80 Suppl 1():S102-5. PubMed ID: 9347655
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.